Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ronopterin in moderate and severe traumatic brain injury
NCT02012582Phase 2Completed
- Sponsor
- Vasopharm
- Start
- Nov 2009
- Primary completion
- Jun 2012
- Countries
- 5
01
Overview
A Phase 2 trial of ronopterin in traumatic brain injury (TBI), sponsored by Vasopharm. Started Nov 2009; status: completed.
02
Drugs
ronopterin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02012582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012582.